o-Toluidine metabolism and effects in the urinary bladder of humanized-liver mice

• Published in: Toxicology (Amsterdam) Vol. 488; p. 153483
• Main Authors: Yokota, Yuka, Suzuki, Shugo, Gi, Min, Yanagiba, Yukie, Yoneda, Nao, Fujioka, Masaki, Kakehashi, Anna, Koda, Shigeki, Suemizu, Hiroshi, Wanibuchi, Hideki
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 01.04.2023
• Subjects: Animals; Bladder; Humanized-liver mice; Humans; Liver; Metabolites; Mice; o-toluidine; Toluidines - toxicity; Urinary Bladder; Urinary Bladder Neoplasms - chemically induced; NAT; 2AMC; Metabolites; NAOTD; o-toluidine; Liver; CYPs; Bladder; Humanized-liver mice; 4AMC; OTD
• ISSN: 0300-483X; 1879-3185
• DOI: 10.1016/j.tox.2023.153483

Occupational exposure to aromatic amines is one of the most important risk factors for urinary bladder cancer. When considering the carcinogenesis of aromatic amines, metabolism of aromatic amines in the liver is an important factor. In the present study, we administered ortho-toluidine (OTD) in the diet to mice for 4 weeks. We used NOG-TKm30 mice (control) and humanized-liver mice, established via human hepatocyte transplantation, to compare differences in OTD-induced expression of metabolic enzymes in human and mouse liver cells. We also investigated OTD-urinary metabolites and proliferative effects on the urinary bladder epithelium. RNA and immunohistochemical analyses revealed that expression of N-acetyltransferases mRNA in the liver tended to be lower than that of the P450 enzymes, and that OTD administration had little effect on N-acetyltransferase mRNA expression levels. However, expression of CYP3A4 was increased in the livers of humanized-liver mice, and expression of Cyp2c29 (human CYP2C9/19) was increased in the livers of NOG-TKm30 mice. OTD metabolites in the urine and cell proliferation activities in the bladder urothelium of NOG-TKm30 and humanized-liver mice were similar. However, the concentration of OTD in the urine of NOG-TKm30 mice was markedly higher than in the urine of humanized-liver mice. These data demonstrate differences in hepatic metabolic enzyme expression induced by OTD in human and mouse liver cells, and consequent differences in the metabolism of OTD by human and mouse liver cells. This type of difference could have a profound impact on the carcinogenicity of compounds that are metabolized by the liver, and consequently, would be important in the extrapolation of data from animals to humans. •OTD induced distinct CYP enzyme expression profiles in mouse and human liver cells.•OTD induced CYP3A4 expression in the liver of humanized-liver mice.•OTD and its metabolites in NOG-TKm30 and humanized-liver mice urine were similar.•OTD had similar effects on the urothelium of NOG-TKm30 and humanized-liver mice.